title: The bioavailability of injectable, amorphous form of aztreonam.
abstract: Amorphos injectable form of aztreonam (BIOKTAM) was prepared. It was shown that after intramuscular or intravenous administration there are not any considerable differences in the bioavailability of aztreonam from BIOKTAM and of the drug from AZACTAM.
authors.affiliation: Department of Pharmacodynamics, School of Medicine, Warsaw, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Sasinowska-Motyl
authors.forename: W
authors.initials: W
authors.lastname: Gumułka
authors.forename: M
authors.initials: M
authors.lastname: Filipek
authors.forename: I
authors.initials: I
authors.lastname: Oszczapowicz
authors.forename: A
authors.initials: A
authors.lastname: Sikora
authors.forename: I
authors.initials: I
authors.lastname: Szczesna
mesh_terms: D000328:Adult; D019540:Area Under Curve; D001398:Aztreonam / Q000737:chemistry / Q000493:pharmacokinetics*; D001682:Biological Availability; D002626:Chemistry, Pharmaceutical; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008657:Metabolic Clearance Rate; D008997:Monobactams / Q000737:chemistry / Q000493:pharmacokinetics*
chemical_list: D008997:Monobactams; D001398:Aztreonam